BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33597953)

  • 1. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus.
    Koga T; Ichinose K; Kawakami A; Tsokos GC
    Front Immunol; 2020; 11():624971. PubMed ID: 33597953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target.
    Koga T; Ichinose K; Kawakami A; Tsokos GC
    Expert Rev Clin Immunol; 2019 Jun; 15(6):629-637. PubMed ID: 30874446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.
    Shin MS; Lee N; Kang I
    Curr Opin Rheumatol; 2011 Sep; 23(5):444-8. PubMed ID: 21720245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 promotes murine lupus.
    Amarilyo G; Lourenço EV; Shi FD; La Cava A
    J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
    Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
    Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
    Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
    J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 and systemic lupus erythematosus: current concepts.
    Nalbandian A; Crispín JC; Tsokos GC
    Clin Exp Immunol; 2009 Aug; 157(2):209-15. PubMed ID: 19604260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
    Martin JC; Baeten DL; Josien R
    Clin Immunol; 2014 Sep; 154(1):1-12. PubMed ID: 24858580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17-producing T cells in lupus.
    Crispín JC; Tsokos GC
    Curr Opin Rheumatol; 2010 Sep; 22(5):499-503. PubMed ID: 20592603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 and lupus: enough to be a target? For which patients?
    Robert M; Miossec P
    Lupus; 2020 Jan; 29(1):6-14. PubMed ID: 31791181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus.
    Liu L; Liu Y; Yuan M; Xu L; Sun H
    Biochem Biophys Res Commun; 2017 Oct; 492(3):453-460. PubMed ID: 28837808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.
    Li H; Boulougoura A; Endo Y; Tsokos GC
    J Autoimmun; 2022 Oct; 132():102870. PubMed ID: 35872102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.
    Szmyrka-Kaczmarek M; Kosmaczewska A; Ciszak L; Szteblich A; Wiland P
    Postepy Hig Med Dosw (Online); 2014; 68():893-8. PubMed ID: 24988609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    Yang J; Yang X; Yang J; Li M
    J Rheumatol; 2018 Jun; 45(6):818-826. PubMed ID: 29545450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells and IL-17 in lupus nephritis.
    Koga T; Ichinose K; Tsokos GC
    Clin Immunol; 2017 Dec; 185():95-99. PubMed ID: 27109641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The star target in SLE: IL-17.
    Yang Y; Yan C; Yu L; Zhang X; Shang J; Fan J; Zhang R; Ren J; Duan X
    Inflamm Res; 2023 Feb; 72(2):313-328. PubMed ID: 36538077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 in systemic lupus erythematosus.
    Crispín JC; Tsokos GC
    J Biomed Biotechnol; 2010; 2010():943254. PubMed ID: 20379379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.